Skip to content

NEI Research News

Thanks to the work of NEI scientists and grantees, we’re constantly learning new information about the causes and treatment of vision disorders. Get the latest updates about their work — along with other news about NEI.

Source
852 items
National Eye Institute logo.

Ten-Year Results on Radial Keratotomy Released

After a decade of patient followup, a National Eye Institute (NEI)-supported study reported today that radial keratotomy (RK) remained a reasonably safe and effective technique to improve distance vision.
National Eye Institute logo.

Corticosteroids for First-Time Optic Neuritis Lowers Risk of Developing Multiple Sclerosis

Over half of all people with first-time optic neuritis, a vision-impairing inflammation of the optic nerve, will eventually develop multiple sclerosis (MS).
National Eye Institute logo.

Treatment for Retinitis Pigmentosa Reported

Most adults with blinding retinitis pigmentosa (RP) should take a daily, 15,000 IU vitamin A supplement, based on results from a large, randomized clinical trial published today in the Archives of Ophthalmology.
National Eye Institute logo.

ETDRS 5-Year Followup Data Released

The National Eye Institute reported today that current treatments for a common, sight-threatening complication of diabetes have proved 95 percent effective in maintaining vision, but 8,000 still go blind each year from this disease.
National Eye Institute logo.

Patient/Donor Blood Type Matching Improves Corneal Transplantation Outcome

Researchers report that donor-recipient tissue typing had no significant long-term effect on the success of corneal transplantation in a nationwide clinical study of over 400 patients at high risk for rejection.
National Eye Institute logo.

Oral Corticosteroids Alone Found Ineffective for Optic Neuritis

Although commonly used, oral corticosteroids alone are ineffective in treating optic neuritis, a debilitating inflammation of the optic nerve, and actually increase a person’s risk for future attacks.
National Eye Institute logo.

Foscarnet and Ganciclovir Compared as Treatment for CMV Retinitis

Results from a large, multicenter clinical trial show that patients with AIDS treated for cytomegalovirus (CMV) retinitis
Glaucoma and the optic nerve

Laser Therapy Show Promise As Alternative to Glaucoma Drugs

Results from two years of patient followup in a randomized clinical trial suggest that argon laser therapy may be a safe and effective alternative to eyedrops as a first treatment for patients with newly diagnosed open-angle glaucoma.
National Eye Institute logo.

Fluorouracil Improves Glaucoma Surgery Outcome

Louis W. Sullivan, Secretary of Health and Human Services, has announced results of a clinical trial demonstrating a 50 percent improvement in surgical control of glaucoma in patients at high risk for blindness.
Two boys smile at the camera. Asymmetric dark spots block parts of the image, representing vision loss from diabetic retinopathy.

Laser Treatment Highly Effective in Treating Diabetic Retinopathy

New findings from a nationwide clinical trial supported by theNational Eye Institute (NEI) provide further evidence that laser treatment is highly effective in preventing visual loss from diabetic eye disease.